The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells

Experimental Eye Research

Volumn 66, Issue 4, 1998, Pages 411-419

  Handa, James T ^a,b   Reiser, Karen M ^a   Matsunaga, Hiroshi ^a   Hjelmeland, Leonard M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advanced glycation endproduct (AGE); Nonenzymatic glycation; Pentosidine; Platelet derived growth factor (PDGF); Retinal pigment epithelium (RPE)

Indexed keywords

BETA ACTIN; PENTOSIDINE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN; RNA; UNCLASSIFIED DRUG;

AGING; ARTICLE; BRUCH MEMBRANE; CATARACT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLAUCOMA; GLYCATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

EID: 18344416357     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1997.0442     Document Type: Article

References (46)

1. Albon J., Karwatowski W. S. S., Avery N., Easty D. L., Duance V. C. Changes in the collagenous matrix of the aging human lamina cribrosa. Br. J. Ophthamol. 79:1995;368-375.
2. Anderson S. S., Tsilibary E. C., Charonis A. S. Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane. J. Clin. Invest. 92:1993;3045-3052.
3. Anderson S. S., Wu K., Nagase H., Stettler-Stevenson W. G., Kim Y., Tsilibary E. C. Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells. Cell Adhesion and Communication. 4:1996;89-101.
4. Betscholtz C., Johnson A., Heldin C. H., Westermark B., Lind P., Urden M. S., Eddy R., Shows T. B., Philpott K., Mellor A. L., Khott T. J., Scott J. DNA sequence and chromosomal localization of human platelet-derived growth factor A chain and its expression in tumor cell lines. Nature. 320:1986;695-699.
5. Boyd-White J., Williams J. C. Jr. Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes. Diabetes. 45:1996;348-353.
6. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1988;1315-1321.
7. Bruel A., Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 127:1996;155-165.
8. Campochiaro P. A., Hackett S. F., Vinores S. A., Freund J., Csaky C., LaRochelle W., Henderer J., Johnson M., Rodriguez I. R., Friedman Z., Dervjanik N., Dooner J. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J. Cell. Science. 104:1994;2459-2469.
9. Charonis A. S., Reger L. A., Dege J. E., Kouzi-Koliakos K., Furcht L. M., Wohlhueter R. M., Tsilibary E. C. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes. 39:1990;807-814.
10. Della N. G., Campochiaro P. A., Zack D. J. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 37:1996;1921-1924.
11. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G. E., Striker L. J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2873-2877.
12. Dunn K. C., Aotaki-Keen A. E., Putkey F. R., Hjelmeland L. M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62:1996;155-169.
13. Dyer D. G., Dunn J. A., Thorpe S. D. R., Bailie K. E., Lyons T. J., McCance D. R., Baynes J. W. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91:1993;2463-2469.
14. Fabunmi R. P., Baker A. H., Murray E. J., Booth R. F. G., Newby A. C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 , and -3 in rabbit aortic smooth muscle cells. Biochem. J. 345:1996;335-342.
15. Fariss R. N., Apte S. S., Olsen B. R., Iwata K., Milam A. H. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J. Path. 150:1997;323-328.
16. Green W. R., Key S. N. Senile macular degeneration: a histopatologic study. Tr. Am. Ophth. Soc. 75:1977;180-254.
17. Gunning P., Ponte P., Okayama H., Engel J., Blau H. M., Kedes L. Isolation and characterization of full length cDNA clones for human alpha, beta, and gamma-actin mRNA's: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3:1983;787-795.
18. Hansch G. M., Wagner C., Burger A., Dong W., Staehler G., Stoeck M. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor β (TGFβ) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J. Cell. Phys. 163:1995;451-457.
19. Heldin C.-H., Ostman A., Eriksson A., Siegbahn A., Claesson-Welsh L., Westermark B. Platelet-derived growth factor: isoform-specific signaling via heterodimeric or homodimeric receptor complexes. Kidney Int. 41:1992;571-574.
20. Ishigooka H., Aotaki-Keen A. E., Hjelmeland L. M. Subcellular localization of bFGF in human retinal pigment epithelium in vitro. Exp. Eye Res. 55:1991;203-214.
21. Johnsson A., Heldin C.-H., Wasteson A., Westermark D., Deuel T. F., Huang J. S., Seeburg P. H., Gray A., Ullrich A., Scrace G., Stroobant P., Waterfield M. D. The c-sis gene encodes a precursor of the B-chain of platelet-derived growth factor. EMBO J. 3:1984;921-928.
22. Karwatowski W. S. S., Jeffreis T. E., Duance V. C., Albon J., Bailey A. J., Easty D. L. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. Br. J. Ophthalmol. 79:1995;944-952.
23. Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9010-9014.
24. Li Y. M., Mitsuhashi T., Wojciechowicz D., Shimizu N., Li J., Stitt A., He C., Banerjee D., Vlassara H. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11047-11052.
25. Martinet Y., Rom W. N., Grotendorst G. R., Martin G. R., Crystal R. G. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. New Eng. J. Med. 317:1987;202-209.
26. Monnier V. M., Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science. 211:1981;491-493.
27. Mudhar H. S., Pollock R. A., Wang C., Stiles C., Richardson W. D. PDGF and its receptors in the developing rodent retina and optic nerve. Development. 118:1993;539-552.
28. Mullarkey C. J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173:1990;932-939.
29. Neeper M., Schmidt A. M., Brett J., Yan S. D., Wang F., Pan Y-C. E., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267:1992;14998-15004.
30. Robbins S. G., Mixon R. N., Wilson D. J., Hart C. E., Robertson J. E., Westra I., Planck S. R., Rosenbaum J. T. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest. Ophthalmol. Vis. Sci. 35:1994;3649-3663.
31. Ross R., Masuda J., Raines E., Gown A. M., Katsuda S., Sashara M., Malden L. T., Masuko H., Sato II. Localization of PDGF-B protein in all phases of atherogenesis. Science. 248:1990;1009-1012.
32. Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
33. Ruiz A., Brett P., Bok D. TIMP-3 is expressed in the human retinal pigment epithelium. Biochem. Biophys. Res. Comm. 226:1996;467-474.
34. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A laboratory manual. 1989;Cold Spring Harbor Laboratory.
35. Sebag J., Buckingham B., Charles M. A., Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch. Ophthalmol. 110:1992;1472-1476.
36. Sell D. R., Monnier V. M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem. 264:1989;21597-21602.
37. Sell D. R., Lapolla A., Odetti P., Fogarty J., Monnier V. M. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 41:1992;1286-1292.
38. Sensi M., Pricci F., Andreani D., Di Mario U. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res. 16:1991;1-9.
39. Shaw S. M., Crabbe M. J. C. Non-specific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions. Biochem. J. 304:1994;121-129.
40. Smith M. A., Sayre L. M., Monnier V. M., Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
41. Swamy M. S., Abraham E. C. Glycation of lens membrane intrinsic proteins. Curr. Eye Res. 11:1992;833-842.
42. Takahashi M., Kushida K., Kawana K., Ishihara C., Denda M., Inoue T., Horiuchi K. Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin. Chem. 39:1993;2162-2165.
43. Tarsio J. F., Wigness B., Rhode T. D., Rupp W. M., Buchwald H., Furcht L. T. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus. Diabetes. 34:1985;477-484.
44. Throckmorton D. C., Brogden A. P., Min B., Rasmussen H., Kashgarian M. PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney International. 48:1995;111-117.
45. Tsilibary E. C., Charonis A. S., Reger L. A., Wohlhueter R. M., Furcht L. T. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J. Biol. Chem. 263:1988;4302-4308.
46. Yan S. D., Schmidt A. M., Anderson G. M., Zhang J., Brett J., Sou Y. S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889-9897.